Newsroom | 17762 results

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California. Flatiron's real-world data and research capabilities are featured across multiple presentations, including 6 research acceptances spanning genitourinary cancers. A cornerstone of Flatiron’s presence at ASCO GU 2026 is the global prostate cancer and bladder cancer Panoramic datasets, which draw from o...

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Truist Securities Virtual Human Capital Conference taking place March 12-13, 2026, with one-on-one investor meetings on Thursday, March 12. The Oppenheimer 36th Annual Healthcare MedTech & Services Conference taking place March 16-19, 2026, with one-on-one investor meetings on Tuesday, March 17. In attendance an...

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Highlights: Net Service Revenues Increase 25.6% to $373.1 Million Net Income of $29.8 Million, or $1.61 per Diluted Share Adjusted Net Income per Diluted Share Increases 28.3% year-over-year to $1.77 Adjusted EBITDA Increases 33.3% year-over-year to $50.3 Million Cash Flow f...

HOUSTON--(BUSINESS WIRE)--Legacy Community Health announces the appointment of Aaron Stewart as its new Chief Operating Officer....

WASHINGTON--(BUSINESS WIRE)--The National Association for Veterans Rights (NAVR) today announced the expansion of its Alliance by launching a new Aid & Attendance division, strengthening its commitment to improving access, transparency, and quality across the full spectrum of Veteran support services. Veterans Care Coordination (VCC), a nationally recognized leader in helping Veterans and surviving spouses access the U.S. Department of Veterans Affairs (VA) Pension with Aid and Attendance b...

PITTSBURGH--(BUSINESS WIRE)--ThoroughCare, a leading provider of integrated care coordination solutions, announces the appointments of Bradley Hill as Chief Executive Officer and Sean O’Donnell as Chief Growth Officer. These strategic additions support the company’s continued innovation, market expansion, and commitment to delivering industry-leading care management technology. With more than 25 years of leadership experience across the healthcare and technology sectors, Bradley Hill steps into...

DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC (“Kinderhook”), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately...

維也納--(BUSINESS WIRE)--(美國商業資訊)-- 歐洲罹患罕見疾病的人數在2700萬至3600萬之譜1，然而，目前僅有約百分之六的患者接受通過核可的療法治療2。知識差距往往延誤診斷與治療的進展，這包括缺少做出知情決策必要的清晰、可靠、易懂的資訊。AOP Health根據研究開發罕見疾病療法30年的經驗，強調跨醫療保健社群進行合作的重要性。在2026年罕見疾病日，該公司加入醫療保健專業人員、研究人員以及患者代表，呼籲密切合作的必要，以產生、分享目前付之闕如的資料並善加利用，進而改善罕見疾病患者的照護。 「從1996年開始耕耘罕見疾病這個領域以來，我們發現創新絕對不能只是單打獨鬥。」AOP Health全球治療領域副總裁Melissa Fellner強調說，「創新必須不斷投資於資料、開放合作與資訊，以患者能夠利用的形式送達他們手上。」 AOP Health配合這種取徑進行五項罕見疾病臨床研究。該公司與多所知名國際大學以及58個患者組織的研究人員合作，這些機構的重心大多置於罕見疾病。這些合作關係的目標是發揮協同效應，加強實證基礎。 合作是進步的關鍵 Haifa Kathrin...

WENEN--(BUSINESS WIRE)--Tussen 27 en 36 miljoen1 mensen in Europa zijn getroffen door een zeldzame ziekte. Toch heeft amper zes procent van deze mensen momenteel toegang tot een goedgekeurde behandeling2. Vorderingen in diagnose en behandeling worden vaak afgeremd door kennisleemten, onder andere wegens gebrek aan duidelijke, betrouwbare en patiëntvriendelijke informatie, nodig om een geïnformeerde beslissingname te ondersteunen. Op basis van 30 jaar ervaring in onderzoek en ontwikkeling van th...

VIENNE--(BUSINESS WIRE)--On estime qu’entre 27 et 36 millions de personnes en Europe1 vivent avec une maladie rare, mais seules 6 % d’entre elles ont actuellement accès à un traitement approuvé2. Les progrès en termes de diagnostic et de traitement sont souvent ralentis par des lacunes dans les connaissances, notamment par le manque d’informations claires, fiables et adaptées aux patients, nécessaires pour prendre des décisions éclairées. Forte de 30 ans d’expérience dans la recherche et le dév...